Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

Mohammad Hojjat-Farsangi; Mahmood Jeddi-Tehrani; Amir Hossein Daneshmanesh; Fariba Mozaffari; Ali Moshfegh; Lotta Hansson; Seyed Mohsen Razavi; Ramazan Ali Sharifian; Hodjattallah Rabbani; Anders Österborg; Håkan Mellstedt; Fazel Shokri

doi:10.1371/journal.pone.0142310

Loading metrics

Open Access

Peer-reviewed

Research Article

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

Mohammad Hojjat-Farsangi,

Affiliations Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
⨯
Mahmood Jeddi-Tehrani,

Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
⨯
Amir Hossein Daneshmanesh,

Affiliation Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Fariba Mozaffari,

Affiliation Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Ali Moshfegh,

Affiliation Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Lotta Hansson,

Affiliations Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯
Seyed Mohsen Razavi,

Affiliation Clinic of Hematology and Oncology, Firozgar Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
⨯
Ramazan Ali Sharifian,

Affiliation Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
⨯
Hodjattallah Rabbani,

Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
⨯
Anders Österborg,

Affiliations Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden
⨯
Håkan Mellstedt ,

* E-mail: hakan.mellstedt@karolinska.se

Affiliation Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
⨯
Fazel Shokri

Affiliations Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
⨯

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

Mohammad Hojjat-Farsangi,
Mahmood Jeddi-Tehrani,
Amir Hossein Daneshmanesh,
Fariba Mozaffari,
Ali Moshfegh,
Lotta Hansson,
Seyed Mohsen Razavi,
Ramazan Ali Sharifian,
Hodjattallah Rabbani,
Anders Österborg

Published: November 12, 2015
https://doi.org/10.1371/journal.pone.0142310

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Chronic lymphoblastic leukemia
Is the Subject Area "Chronic lymphoblastic leukemia" applicable to this article?

Thanks for your feedback.
Serum proteins
Is the Subject Area "Serum proteins" applicable to this article?

Thanks for your feedback.
Antibody response
Is the Subject Area "Antibody response" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.